Three graphs compare cumulative biochemical failures over time for HDR brachytherapy and SBRT prostate treatments. Graph A, labeled 'Overall,' shows P<.001. Graph B, 'Favorable intermediate risk,' shows P=.001. Graph C, 'Unfavorable intermediate risk,' shows P=.02.

Among men with intermediate-risk #ProstateCancer, #SBRT was associated with lower biochemical failure and fewer acute genitourinary adverse events compared to #HDRBrachytherapy, with similar late quality of life.

ja.ma/46q0Pdy